Quantbot Technologies’s Omega Protein OME Stock Holding History

Quantbot Technologies’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-800	Closed	-$16K	–	1529
2017 Q1	$16K	Buy	+800	New	+$18.6K	﹤0.01%	1025

Other funds holding OME

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's OME Position: Q2 2017 in Review

Quantbot Technologies sold out of Omega Protein (OME) in Q2 2017, closing a stake of 800 shares — an estimated $16K sold.

Quantbot Technologies first reported a position in OME in Q1 2017 and held it in 1 quarter. The position peaked at $16K in Q1 2017. 140 funds tracked by Wall St. Rank hold OME as of Q2 2017.

Quantbot Technologies reported no remaining Omega Protein position as of Q2 2017 after selling out during the quarter.
Quantbot Technologies sold 800 Omega Protein shares in Q2 2017, an estimated $16K.
Quantbot Technologies first reported a position in Omega Protein in Q1 2017 and held it in 1 quarter.
Quantbot Technologies's Omega Protein position peaked at $16K in Q1 2017.
140 funds tracked by Wall St. Rank held Omega Protein as of Q2 2017.

Based on Quantbot Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.